934831-76-2

Upstream product

• 934831-74-0 (+)-(2S)-N-[(1R,2S)-1-hydroxy-3-cyclohexene-2-carbonyl]bornane-10,2-sultam 
• 58479-61-1 tert-butylchlorodiphenylsilane 
• 934831-73-9 (+)-(2S)-N-[(2S,3R)-2-(ethenyl)-3-(hydroxy)-6-heptenoyl]bornane-10,2-sultam 
• 2100-17-6 4-pentenal 
• 94668-55-0 (1S)-N-crotyl-2,10-camphorsultam 

Downstream Products

• 934831-78-4 (+)-(2S)-N-[(3aS,4S,5R,7aS)-2,2-dimethyl-5-(((tert-butyldiphenyl)silyl)oxy)hexahydro[1,3]benzodioxol-4-carbonyl]bornane-10,2-sultam 
• 934831-77-3 (+)-(2S)-N-[(1R,2R,3S,4R)-1-(((tert-butyldiphenyl)silyl)oxy)-3,4-(dihydroxy)cyclohexane-2-carbonyl]bornane-10,2-sultam 

Relevant academic research and scientific papers

Enantioselective synthesis of a potential key intermediate for the total synthesis of fumagillin

Key intermediate, 7, of a projected total synthesis of the anti-angiogenesis compound Fumagillin 1 and the semi-synthetic analogue TNP-470 2, has been prepared in enantiomerically pure form by employing an early nucleophilic addition ring closure [NARC] s